Literature DB >> 11239763

Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer.

H Nakama1, B Zhang, X Zhang.   

Abstract

This study was carried out to assess, from the aspects of cost-effectiveness and diagnostic validity, the optimum cut-off point for immunochemical occult blood testing using a 2-day method as a means of screening for colorectal cancer. Four thousand, two hundred and sixty asymptomatic individuals were subjects of this study. They gave samples for an immunochemical fecal occult blood test, and colonoscopy was carried out during a medical check-up. For evaluation of the optimum cut-off point, three cut-off levels of fecal haemoglobin, 50, 150 and 300 ng/ml, were used. A total of 27 patients with colorectal cancer were diagnosed. The average costs to detect one patient with colorectal cancer and the sensitivity and specificity of these three cut-off points of fecal haemoglobin were evaluated. The average costs for the detection of one cancer case were calculated as $2870.45 for cut-off level of 50 ng/ml, $2492.98 for that of 150 ng/ml and $3329.09 for that of 300 ng/ml, respectively. The sensitivity and specificity were calculated as 89 and 94% for the 50 ng/ml cut-off level, 81% and 96% for the 150 ng/ml cut-off level and 56 and 97% for the 300 ng/ml cut-off level, respectively, indicating a significant difference in the sensitivity between the 50 and 300 ng/ml levels (P<0.05), as well as between the 150 and 300 ng/ml levels (P<0.05), and a significant difference in the specificity between the 50 and 300 ng/ml levels (P<0.05). However, no significant difference was observed in the specificity between the 50 and 150 ng/ml levels. The findings show that 150 ng/ml of fecal haemoglobin is the optimal cut-off point when carrying out the OC-Hemodia test as a means of screening for colorectal cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11239763     DOI: 10.1016/s0959-8049(00)00387-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  13 in total

1.  Fecal immunochemical test accuracy in average-risk colorectal cancer screening.

Authors:  Vicent Hernandez; Joaquin Cubiella; M Carmen Gonzalez-Mao; Felipe Iglesias; Concepción Rivera; M Begoña Iglesias; Lucía Cid; Ines Castro; Luisa de Castro; Pablo Vega; Jose Antonio Hermo; Ramiro Macenlle; Alfonso Martínez-Turnes; David Martínez-Ares; Pamela Estevez; Estela Cid; M Carmen Vidal; Angeles López-Martínez; Elisabeth Hijona; Marta Herreros-Villanueva; Luis Bujanda; Jose Ignacio Rodriguez-Prada
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

2.  Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.

Authors:  Motoaki Kuriyama; Jun Kato; Koji Takemoto; Sakiko Hiraoka; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

3.  Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010.

Authors:  Desmond J Leddin; Robert Enns; Robert Hilsden; Victor Plourde; Linda Rabeneck; Daniel C Sadowski; Harminder Signh
Journal:  Can J Gastroenterol       Date:  2010-12       Impact factor: 3.522

Review 4.  Familial colorectal cancer screening: When and what to do?

Authors:  Giovanna Del Vecchio Blanco; Omero Alessandro Paoluzi; Pierpaolo Sileri; Piero Rossi; Giuseppe Sica; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

5.  Single immunochemical fecal occult blood test for detection of colorectal neoplasia.

Authors:  Dae Kyung Sohn; Seung-Yong Jeong; Hyo Seong Choi; Seok-Byung Lim; Jin Myeong Huh; Dae-Hyun Kim; Dae Yong Kim; Young Hoon Kim; Hee Jin Chang; Kyung Hae Jung; Joong-Bae Ahn; Hyun Kyung Kim; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

Review 6.  Colorectal cancer screening: 20 years of development and recent progress.

Authors:  Miroslav Zavoral; Stepan Suchanek; Ondrej Majek; Premysl Fric; Petra Minarikova; Marek Minarik; Bohumil Seifert; Ladislav Dusek
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

7.  Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.

Authors:  Kevin Selby; Emma H Levine; Cecilia Doan; Anton Gies; Hermann Brenner; Charles Quesenberry; Jeffrey K Lee; Douglas A Corley
Journal:  Gastroenterology       Date:  2019-08-22       Impact factor: 22.682

8.  Colorectal cancer screening for average-risk North Americans: an economic evaluation.

Authors:  Steven J Heitman; Robert J Hilsden; Flora Au; Scot Dowden; Braden J Manns
Journal:  PLoS Med       Date:  2010-11-23       Impact factor: 11.069

9.  Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?

Authors:  G Grazzini; C B Visioli; M Zorzi; S Ciatto; F Banovich; A G Bonanomi; A Bortoli; G Castiglione; L Cazzola; M Confortini; P Mantellini; T Rubeca; M Zappa
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

10.  Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.

Authors:  G Castiglione; C B Visioli; S Ciatto; G Grazzini; A G Bonanomi; T Rubeca; P Mantellini; M Zappa
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.